CPhl China 2023 Invitation

2023/04/20

Related News

Hichi Pharmaceutical's Iodixanol API Approved for Market
September 9, 2024Iodixanol is the active pharmaceutical ingredient for iodixanol injection, a contrast agent used for intrathecal contrast, cardiovascular angiography, and intravenous urography. Its mechanism of actio...view
Adverse Reaction and Treatment of Contrast Medium
December 3, 2020Adverse drug reactions refer to harmful reactions that have nothing to do with the purpose of medication or accidentally occur under normal usage and dosage of qualified drugs.view
Beilu was awarded the “Top 100 Small and Medium-sized Private Enterprises in Beijing” and “Top 100 Private Enterprises in Beijing for Social Responsibility”
September 17, 2021Recently, the Beijing Municipal Federation of Industry and Commerce and the Beijing Branch of China Construction Bank jointly held the“2021 Beijing Top 100 Private Enterprises Press Conference”.view
What is the Contrast Material? How Does It Work?
July 5, 2022Ⅰ. What is the contrast material?Contrastive material is used to improve the contrast of the images produced by X-rays, computed tomography (CT), magnetic resonance (MR) imaging, and ultrasound, allo...view
Frequently Asked Questions about Iodine Contrast Users (3)
May 13, 20211. Does the iodinated contrast agent need to be preheated? Can the patient benefit from it?Preheating the iodinated contrast agent before use is recognized as the best method of application.view
Introduction of Contrast Medium
February 24, 2021Contrast medium can be divided into two categories.view

CPhl China 2023 Invitation

Hichi Pharmaceutical's Iodixanol API Approved for Market

Adverse Reaction and Treatment of Contrast Medium

Beilu was awarded the “Top 100 Small and Medium-sized Private Enterprises in Beijing” and “Top 100 Private Enterprises in Beijing for Social Responsibility”

What is the Contrast Material? How Does It Work?

Frequently Asked Questions about Iodine Contrast Users (3)

Introduction of Contrast Medium